The FDA recently approved STELARA, a prescription medication for adults suffering from Crohn's disease. Here's what you need to know: 1. STELARA is manufactured by Janssen Biotech. 2. This treatment ...

Medicare and its beneficiaries are paying significantly more for Stelara, Johnson & Johnson’s (NYSE:JNJ) popular biologic drug used to treat autoimmune diseases when obtained through pharmacies rather ...

The approval is supported by evidence from adequate and well-controlled studies of Stelara. The Food and Drug Administration (FDA) has expanded the approval of Stelara ® (ustekinumab) to include ...

First and Only Anti-IL-12/23 Treatment Approved for Adult Patients Living with Psoriatic Arthritis HORSHAM, Pa., Sept. 23, 2013-- Janssen Biotech, Inc., announced today that the U.S. Food and Drug ...

The approval of ustekinumab in pediatric patients was based on data from a phase 3 open-label, single-arm study (CADMUS Junior). The Food and Drug Administration (FDA) has expanded the approval of ...

Johnson & Johnson’s (NYSE:JNJ) Stelara could become the #2 drug in the Crohn’s Disease market over the next few years. Crohn’s Disease causes inflammation of the digestive tract. J&J’s top selling ...

Please provide your email address to receive an email when new articles are posted on . The FDA on Monday approved Stelara for the treatment of adults with moderately to severely active ulcerative ...

Johnson & Johnson recently launched Stelara for the treatment of adult patients with moderate to severe plaque psoriasis. Although Stelara is entering a crowded treatment room for psoriasis, this ...

The FDA recently approved STELARA, a prescription medication for adults suffering from Crohn’s disease. Here’s what you need to know: 1. STELARA is manufactured by Janssen Biotech. 2. This treatment ...